MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

01 Aug 2026 Evaluate
The revenue for the June 2026 quarter is pegged at Rs. 2069.65 millions, about 5.57% up against Rs. 1960.47 millions recorded during the year-ago period.A slim rise of 16.05% was recorded in the Net profit for the quarter ended June 2026 to Rs. 211.31  millions  From Rs. 182.08 millions.OP of the company witnessed a marginal growth to 436.34 millions from 394.54 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2069.65 1960.47 5.57 2069.65 1960.47 5.57 8868.71 7827.48 13.30
Other Income 17.44 5.93 194.10 17.44 5.93 194.10 83.54 62.24 34.22
PBIDT 436.34 394.54 10.59 436.34 394.54 10.59 1792.67 1461.98 22.62
Interest 55.00 58.40 -5.82 55.00 58.40 -5.82 230.76 185.41 24.46
PBDT 381.34 336.14 13.45 381.34 336.14 13.45 1561.91 1276.57 22.35
Depreciation 99.91 97.52 2.45 99.91 97.52 2.45 399.19 343.37 16.26
PBT 281.43 238.62 17.94 281.43 238.62 17.94 1162.72 933.20 24.59
TAX 70.12 56.54 24.02 70.12 56.54 24.02 286.62 249.39 14.93
Deferred Tax 9.12 6.54 39.45 9.12 6.54 39.45 27.29 52.99 -48.50
PAT 211.31 182.08 16.05 211.31 182.08 16.05 876.10 683.81 28.12
Equity 93.65 88.65 5.64 93.65 88.65 5.64 93.65 88.65 5.64
PBIDTM(%) 21.08 20.12 4.76 21.08 20.12 4.76 20.21 18.68 8.22

SMS Pharmaceuticals Share Price

377.30 20.10 (5.63%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: